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A connection between lipid rafts and Alzheimer’s disease has been studied during the
last decades. Mathematical modeling approaches have recently been used to correlate
the effects of lipid composition changes in the physicochemical properties of raft-like
membranes. Here we propose an agent basedmodel to assess the effect of lipid changes
in lipid rafts on the evolution and progression of Alzheimer’s disease using lipid profile data
obtained in an established model of familial Alzheimer’s disease. We have observed that
lipid raft size and lipid mobility in non-raft domains are two main factors that increase
during age and are accelerated in the transgenic Alzheimer’s disease mouse model. The
consequences of these changes are discussed in the context of neurotoxic amyloid β
production. Our agent based model predicts that increasing sterols (mainly cholesterol)
and long-chain polyunsaturated fatty acids (LCPUFA) (mainly DHA, docosahexaenoic
acid) proportions in the membrane composition might delay the onset and progression
of the disease.
Keywords: Alzheimer’s disease, lipid rafts, membrane domains, lipid composition, mathematical modeling, agent
based model, DHA, cholesterol
INTRODUCTION
Alzheimer’s disease (AD) is the most frequent dementia worldwide, affecting more than 40 million
people worldwide, with a prevalence of around 10% of the population above 65 years, which doubles
every 10 years (Han and Han, 2014). AD is a degenerating irreversible disease that impairs memory
and cognitive abilities and, at present, has no cure. AD occurs in two forms: the familial and
the sporadic. Although the familial type is known to be associated to several well-defined genetic
alterations (Tanzi, 2012; Loy et al., 2014), it does only explain<1% of AD cases currently diagnosed.
Abbreviations: ηapp, apparent microviscosity; AD, Alzheimer’s disease; APP, amyloid precursor protein; APP/PS1, double
transgenic mice model of AD carrying mutated forms of APP and PSEN1; ARA, arachidonic acid; DHA, docosahexaenoic
acid; DPH, 1,6-diphenyl-1,3,5-hexatriene.LCPUFA, long-chain polyunsaturated fatty acids; WT, wild-type littermates.
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Conversely, in the sporadic AD, the most common
neurodegenerative form (99% of all cases, Holtzman et al.,
2011), the causes are largely unknown, and most evidence
indicate that the genome has only a partial contribution on the
onset of the disease.
One of the neuropathological hallmarks in AD is the
occurrence of senile plaques in neuronal tissue, caused by the
accumulation of the neurotoxic amyloid β (Aβ) proteins. Aβ
peptides result from the sequential activity of two enzymes,
namely β-secretase and γ-secretase (Blennow et al., 2006), which
cleavage the transmembrane amyloid precursor protein (APP).
According to the amyloidogenic hypothesis of AD, this is a
major responsible cause of AD. Aβ peptides become pathological
because the 1–40 and 1–42 fragments have a trend to oligomerize
and fibrillate, and eventually to precipitate generating neurotoxic
aggregates (Rushworth and Hooper, 2010; Claeysen et al., 2012;
Hicks et al., 2012) designated as senile plaques. Alternatively,
APP protein may be processed in a non-amyloidogenic manner
by the α-secretase instead of β-secretase, which release non-
amyloidogenic peptides, whose exact function in the normal
brain has not been completely elucidated (Claeysen et al., 2012;
Postina, 2012).
Furthermore, several recent reports have demonstrated a
clear relationship between lipid rafts and amyloidogenic APP
processing (reviewed in Rushworth and Hooper, 2010; Vetrivel
and Thinakaran, 2010; Hicks et al., 2012). This relationship
appears to be tightly linked to the lipid composition and
physicochemical properties of lipid rafts (Martín et al., 2010),
and is present even at the earliest stages of the disease (Fabelo
et al., 2014; Díaz et al., 2015). Lipid rafts are membrane
microdomains characterized by a differentiated lipid and protein
composition that segregate within the plasma membrane (Brown
and London, 2000; Simons and Ehehalt, 2002; Hicks et al.,
2012). These chemical features, confer them some particular
physicochemical properties including closer lipid packing, rather
restricted lateral movement, higher viscosity, and differential
thermodynamic properties, compared to the surrounding non-
raft regions (Brown and London, 2000; Pike, 2006; Klymchenko
and Kreder, 2014). Lipid composition of lipid rafts is the most
important biochemical parameter in determining their structure
and physicochemical properties (Sonnino and Prinetti, 2013). In
particular, the proportion of cholesterol, a key element regarding
their maintenance and stability is higher in these domains than in
their surroundings. In addition, sphingolipids and saturated fatty
acids are notably augmented compared to non-raft membrane
domains, these contributing to the higher density, and degree
of packing of lipid rafts (Simons and Ehehalt, 2002; Róg and
Vattulainen, 2014). Further, long-chain polyunsaturated fatty
acids (LCPUFA), including docosahexaenoic acid (DHA), and
arachidonic acid (ARA) have been found to be present in lipid
raft from nerve cells in the brain of both animal models and
humans, yet to much lower amounts than in non-raft domains
(Martín et al., 2010; Fabelo et al., 2012), but still they are essential
to allow a degree of freedom required for protein-protein and
lipid-protein interactions within lipid rafts.
In the context of AD, it is known that the molecules involved
in the production of Aβ are segregated inside and outside lipid
rafts. In particular, APP is mainly, but not exclusively, located
outside the lipid rafts, while the β-secretase and γ-secretase
predominantly reside inside (Rushworth and Hooper, 2010;
Vetrivel and Thinakaran, 2010; Fabelo et al., 2014). These
observations make lipid rafts principal actors in the study of the
evolution of AD, since under non-pathological situations, APP
is cut outside lipid rafts by the α-secretase and then inside by γ-
secretase, while in the pathological condition, APP is sequentially
cleavage inside raft domains by β- and γ-secretases (Vetrivel and
Thinakaran, 2010; Hicks et al., 2012) This issue have been the
subject of many studies aimed to elucidate the role of lipid rafts
on the emergence of AD (Rushworth and Hooper, 2010; Zhou
et al., 2014), although the precise role of lipid environment in the
evolution of AD remains largely misunderstood.
One of the recent findings that pinpoint to lipid rafts as critical
elements in the development of AD, has been the demonstration
that lipid rafts are subjected to age-dependent changes, which has
been coined as “lipid raft aging hypothesis” (Fabelo et al., 2012).
Aging is known to be the main risk factor in the development
of AD, and the available evidence have demonstrated that the
time-course of lipid raft alterations are more pronounced and
accelerated in APP/PS1 brains, a familial model of AD (Fabelo
et al., 2012). Further, in line with these observations, we have
recently demonstrated the presence of altered lipid rafts in
human brains, even at the earliest stages of the disease (stages
I/II of Braak and Braak). It has also been demonstrated that
changes in lipid composition may alter the thermodynamic and
physicochemical properties of lipid rafts (Müller et al., 2001;
Wood et al., 2002; Diaz et al., 2012), which, on their own, can
influence the evolution of AD. Interestingly, in animal models
of familial AD, the induced increase in the production of Aβ
provokes, in turn, changes in the observed lipid composition
(Müller et al., 2001; Wood et al., 2002). Thus, it seems that the
system is positively fed back to increase AD neuropathology. In
this work we aim to elucidate how changes in lipid composition
influence the biophysical properties of lipid rafts and non-raft
domains, and how the alterations in lipid rafts might affect the
rate of production of Aβ and plaque formation in the evolution
of AD. How changes in lipid composition influence?
The experimental analysis of the structure, biophysical
properties, dynamic behavior and composition of lipids rafts
encompass many difficulties and require different, independent
methodological approaches. In this regard the mathematical
approach represents a valid and potentially useful alternative
to the study of the physicochemical properties and dynamic
behavior of lipid rafts and their relation with its composition
under normal and pathological conditions. In recent years,
several studies have been published using in silico approaches
(Nicolau et al., 2006, 2007; Burrage et al., 2007; Richardson et al.,
2007; Zhang et al., 2008; Herrera and Pantano, 2012; Soula et al.,
2012). In some of these contributions, coarse grain models of cell
membranes and lipid rafts have been reported (Marrink et al.,
2008; Risselada and Marrink, 2008; Perlmutter and Sachs, 2009,
2011; Kucerka et al., 2010; Schäfer and Marrink, 2010; de Joannis
et al., 2011; Risselada et al., 2011; Rosetti and Pastorino, 2011,
2012; Baoukina et al., 2012; Fischer et al., 2012; Muddana et al.,
2012; Bennett and Tieleman, 2013; Davis et al., 2013; Hakobyan
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and Heuer, 2013; Marrink and Tieleman, 2013; Barnoud et al.,
2014). These studies have allowed unraveling the effects and
roles of different types of lipids on the structure of these lipid
domains, some of which were confirmed in vitro and verified
experimentally using artificial membrane vesicles (Barenholz and
Thompson, 1980; Finegold, 1993; Maulik and Shipley, 1996).
However, at present, there has been no attempt to model the
formation of lipid rafts and relate this to the pathogenesis of AD
using real nerve cell membranes based on in vivo data, thereby
using real nerve cell membranes. In this article, we propose a
mathematical model to deal with this issue. We ask ourselves
here on how the lipid composition of these domains influence
the biophysical properties of lipid rafts (measured in terms of
size, number, viscosity, and proportion of membrane lipid rafts)
during normal aging and also along the evolution of senile
plaque formation in animal models of AD. We also inquired
on the effect of these biophysical changes on the emergence of
AD neuropathology. Finally, based in the mathematical model
predictions on the evolution of the physicochemical properties
of these domains in AD, we were able to assess how changes in
the lipid composition of raft and non-raft microdomains might
restore membrane stability and modify AD-like pathogenic
processes in an animal model of AD. Our findings lead us to
sketch out potential therapies aiming to delay the pathological
evolution of AD.
MATERIALS AND METHODS
Experimental Data
Isolation of Lipid Rafts and Non-raft Fractions
WT and APP/PS1 mice were sacrificed using carbon dioxide.
All experimental manipulations were performed following the
procedures authorized by the Ethics Committee formanipulation
of laboratory animals at University of La Laguna (Spain).
Frontal cortices of four animals from each age and genotype
were dissected out and rapidly immersed in liquid nitrogen
until membrane domains purification. Lipid raft and non-
raft fractions were isolated by ultracentrifugation in sucrose
gradients following the protocols described in detail in Diaz et al.
(2012) and Fabelo et al. (2012). After differential centrifugation,
fractions were collected from top to bottom. The first 2mL
fractions, contained the lipid rafts fractions, while the last fraction
of the gradient and the pellet were collected and designated as
non-raft fractions. Both fractions were routinely tested for purity
in Western blot assays using different lipid raft and non-raft
protein markers (i.e., anti-flotillin 1 for lipid rafts and anti-α1
subunit of the Na+/K+ ATPase for non-raft plasma membrane)
following Fabelo et al. (2012).
Microviscosity Estimates of Lipid Rafts and Non-raft
Domains
For this purpose we determined the steady-state fluorescence
anisotropy of the non-polar 1,6-diphenyl-1,3,5-hexatriene
(DPH) following the methodology described in detail in
Diaz et al. (2012). Fluorescence polarization spectroscopy
was performed using 355 nm excitation filter and 420 nm
emission filter in an Appliskan multiplate reader (Thermo
Scientific), equipped with appropriate polarizers. Controls
containing the fluorophores alone were concurrently examined
to correct for light scattering and intrinsic fluorescence.
Microviscosity estimates (η) were derived from DPH steady-
state anisotropy values using an adaptation of the Perrin equation
(Lakowicz, 1999) for rotational depolarization of nonspherical
fluorophore as described previously for DPH (de Laat et al.,
1977).
Lipid Raft Lipid Composition
The lipid composition data (including lipid classes and fatty acids
composition) from cortical lipid rafts, non-raft domains, and
whole nerve cell membranes both in WT and APP/PS1 animals
at the different ages (3, 6, 9, and 14 months) used here, have been
recently published by our group (Diaz et al., 2012; Fabelo et al.,
2012). Further, based on these data we have also delved into some
relevant biophysical and thermodynamic properties of lipid rafts
in these same genotypes and ages and reported them in Diaz et al.
(2012).
Mathematical Model
According to our previous findings, the nerve cell membrane of
cortical tissue inmouse and human brain has the form of an agent
based model, as stated in the approaches previously presented
elsewhere (Wurthner et al., 2000; Jicha and Markesbery, 2010).
Here, we have considered each element representing a lipid
group. Based on previous findings by our group on the
involvement and importance of lipids in the development and
progression of Alzheimer’s disease in humans and transgenic
mice models (Martín et al., 2010; Fabelo et al., 2012, 2014) we
simplified the membrane lipid matrix and defined five groups of
lipids: sterols (cholesterol and sterol esters); n-3 LCPUFA DHA
and n-6 LCPUFA (mainly arachidonic acid, ARA); monoenoic
fatty acids and saturated fatty acids. Although phospholipids
in the plasma membrane are esterified by two fatty acids, we
assumed that they move rather independently, which could be
a reasonable assumption if there is no much segregation of
fatty acids between LCPUFA-containing phospholipid (which
in the brain are mainly esterifying phosphatydylethanolamine,
phosphatydylserine, and phosphatidylinositol) (Farooqui et al.,
2000).
The model represents a fragment of membrane semi-layer
(200 × 200 units) with a torus-like topology. In this system,
each lipid can interact with four neighbors (up, down, left,
and right). There is a given interaction between each pair
of neighboring lipids that are calculated based on the non-
retarded and additive London-Van der Waals (LVW) attraction
(Hamaker, 1937; Israelachvili, 2011). We can assume this type of
interactions because forces between lipids within the semilayer
occurs between lipid molecules which are very close to each other
and because the medium is highly enriched in membrane lipids
(see the recent updated review by Nicolson, 2014).
A key feature in the present agent model is the quantification
of the interaction between and amongst lipid groups. In this
model, each lipid is represented as the minimum cylinder that
can contain it (see Figure 1). This approach has been proven to
be useful to predict the behavior of lipids in the cell membrane
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FIGURE 1 | Lipid groups representation. Lipid molecules are simplified as the cylinder that best fits their volume and then are parametrized by their radiuses (Ri,
Rj), lengths (L) and mean distance between them (D). Finally they are disposed in a matrix to simulate the cell membrane.
(Kumar, 1991). Accordingly, the LVW interaction between them
is given by Equation 1 (Israelachvili, 2011).
LVWi,j =
AL
12
√
2D3/2
(
RiRj
Ri + Rj
)1/2
(1)
In this Equation,A is the Hamaker constant, with a value between
10−20 and 10−19 J (in vacuum). L represents the length of each
lipid. Its magnitude (in Å) corresponds to the length of the lower
interacting lipid. D is the distance between lipids (in Å) while Ri
and Rj represent the radiuses (Å) of the different lipid groups.
In the case of saturated fatty acids, its length and width were
determined by using Equations (2) and (3) (Israelachvili, 2011):
length = 0.154+ 0.1265n nm (2)
volume = 27.4+ 26.9n · 10−3nm3 (3)
where n is the number of carbons; this value being the mean
number of carbons in the fatty acids in each lipid group. In
the case of unsaturated fatty acids the double bonds increase
the volume of the minimum cylinder, as double bonds increase
the width of the fatty acids. We have calculated their width
based in the number of double bonds and their physicochemical
parameters (see Prediction of lipids rafts section). Using Equation
1 and the physicochemical parameters for each lipid, the
matrix of interaction forces between pairs of lipids (LVWi,j)
was determined. Here, it is worth noting that these physical
parameters do not represent the actual dimensions of the
molecules, but describe the dimension of the cylinder which best
represent the interaction of a lipid group in the context of the cell
membrane.
In ourmodel, two adjacent lipids can exchange their positions,
the direction of anymovement being random. Based in the values
of the matrix of interaction (LVWi,j) we were able to assign a
probability of movement for each lipid group. For the calculation
of this probability we took into account the force keeping each
lipid in its current position, this being the sum of all forces acting
on the exchanging lipids of the four surrounding molecules. In
the case of sphingolipids an additional parameter is required
since it is necessary to consider the interdigitation between the
two membrane leaflets demonstrated for this lipid class (Maulik
et al., 1986) (see later).
The above procedure provides two values of force, which are
the corresponding energies that keep each lipid in its current
position. In any instance switch movements will occur if both
values are lower than a given threshold defined by a uniform
probability distribution. This procedure lets more interchanges
between pairs of lipids that have lower interacting forces in their
current state. Further, each lipid-lipid interaction have a chance
to switch, being the lipid to be switched selected randomly.
Model Mobility and Lipid Rafts
The proposed model was designed to predict the occurrence of
lipid rafts, the influence of the membrane lipid composition on
this process, the time-course of the changes associated with aging
and genotype, and the potential changes in their physicochemical
parameters.
We define mobility within the lipid rafts as the quotient
number of switching movements observed in each lipid in a
50 times iterations set over 100. Lipids with no movement’s
restrictions will have 100 switching movements in average
(2 movements in each iteration), so values of mobility close to
one represent free moving lipids. Accordingly, a mobility value of
1 indicates that themolecule is free tomove through, while values
lower than 1 indicate the existence of some sort of switching
restrictions. This mobility model based measurements can be
easily compared with the observed membrane microviscosities
measured in nerve cells from animal models, using anisotropy
fluorescence spectroscopy (de Laat et al., 1977; Lakowicz, 1999).
Repeated model runs showed that a mobility value of 0.36 well
describes those regions that can be considered as lipid rafts.
Accordingly, regions with mobility values below this threshold
will be considered as lipid rafts and values above this value as
non-raft regions.
We were able to estimate the model physicochemical
parameters (longitude and width) for each group of the model
lipids to be used in our model. For this purpose we make use of
published data of the membrane lipid composition of neocortex
in WT and APP/PS1 mice (Fabelo et al., 2012). Also, based
on these data we determined the threshold mobility value to
define lipid rafts. For this determination, we used the above
indicated initial parameters values. In the case of cholesterol, the
physicochemical parameters were estimated using the language
of molecular structure modeling Jmol. These parameters, which
were refined within intervals, were: (1) the dependence of lipid
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width on the number of double bonds and (2) the width and
length of the sterol group. First, an initial search of a 50% above
and below the initial value of all parameters let us to restrict
the search to intervals where lipid rafts were observed. The best
solution predicting the lipid composition of lipid rafts under all
conditions found in 2000 solutions was selected.
Estimation of the Number and Size of Lipid
Rafts
In order to obtain a measure of the mean size and the
approximate number of lipid rafts predicted by the model under
each situation. Some properties in the domains must be assumed,
these are: (1) Membrane domains are round-shaped, and (2) All
lipid raft domains would have the same size.
These assumptions are not very far from the actual situation
(see Figure 3). Under assumption 1, the area and the perimeter
of each domain can be estimated using circle geometry functions,
as follows:
Area (A) = pi · radius2 (4)
Perimeter (P) = 2pi · radius (5)
On the other hand, under assumption 2, the total perimeter of raft
domains as well as their total area can be obtained by counting the
number of domains (n), and applying the following equations:
Total area = area (A) · n (6)
Total perimeter = perimeter (P) · n (7)
Total area and total perimeter can be calculated from data on
Figure 3. Total area is just the number of spots on the matrix
which have a mobility value lower than a previously defined
threshold value. The total perimeter was calculated by summing
the outcomes of differential function applied to the data of lipid
raft identification matrix from left to right and from up to down.
The lipid rafts identification matrix was obtained transforming
the data of Figure 3 on a matrix of the same dimension, in which
a value of one is assigned when the mobility was under the
defined threshold value and zero when it did not.
Once the total perimeter and total area were obtained,
Equations (6) and (7) can be replaced on Equations (4) and
(5), providing a system of two equations with two unknowns
variables (number and radius), which can be easily solved.
These number (n) and radius (r) values correspond to the
estimations of the number and size of lipid raft membrane
domains, respectively.
n = P
2
4·pi ·A (8)
r = 2·A
P
(9)
In these equations, A and P represent the area and perimeter of
the lipid rafts, respectively. Estimates of changes in surface area
of non-rafts regions can be obtained by following the changes in
radius size of lipid domains (r), as we are considering a piece of
membrane of constant surface. Increasing values of lipid rafts size
(r) result in decreasing value of surface area of non-rafts regions.
The Possibility that AD-like Pathology can
be Modified
Based in the model, it was possible to propose a set of changes
in the lipid composition of cell membrane microdomains
which could eventually displace the parameters obtained for old
transgenic APP/PS1 animals toward the values corresponding to
those of young Wild-type animals.
The initial pathological condition chosen was that of 9
months old transgenic APP/PS1 mice, which corresponds to a
pathological but, not irreversible condition (Diaz et al., 2012;
Fabelo et al., 2012). The final, healthy condition, we wanted to
move to, was that of 3 months Wild-type mice. To accomplish
this, we changed in the mathematical model the composition
of each lipid group on the cell membrane domains of the 9
months transgenic mice by 50% in the direction opposing the
pathological change in lipid rafts from transgenic mice.
RESULTS
Insights into Lipid Raft Composition
The comparison of some observed and model-predicted
membrane features are shown in Figure 2. Figures 2B,C
compare the experimentally observed data and the predicted
model composition for lipid rafts in WT and APP/PS1 mice
(Fabelo et al., 2012), respectively. In addition, it can be seen
(Figure 2A) the differences between the observed composition
of selected groups of lipids in the whole membrane (Diaz et al.,
2012) and the model-predicted composition of the lipid raft
(Figure 2C).
Based in the model, we have also assessed the predicted
membrane lipid structure in WT and APP/PS1 mice under
different experimental conditions, including the changes that are
found in aging animals. The results are shown in Figure 3.
As it can be seen, the model was able to predict some of the
experimental observations. First, there was a good agreement
with the observed decrease in the concentration of sterols in lipid
rafts with respect to the whole nerve cell membrane. Also, the
model reproduced well the observed increase of saturated fatty
acids and sphingolipids within the lipid rafts. Finally, the model
also showed that the composition ofmonoenoic fatty acids, DHA,
and n-6 LCPUFA on rafts domains and total membrane followed
the changes demonstrated experimentally in both Wild-type and
APP/PS1 mice (Fabelo et al., 2012).
Sphingolipids are essential and characteristic components
of lipid rafts, and partly responsible for the higher degree of
lateral packing of lipid within these domains endowing them
with a limited lateral mobility (Maulik et al., 1986). Compared
with other phospholipids, i.e., phosphatidylcholine, the main
structural dissimilarity is chain length in sphingomyelins,
where the N-acyl group (usually highly saturated) can be up
to 10 carbons longer than the sphingosine (Barenholz and
Thompson, 1980). Such a chain disparity give sphingomyelins
the unique ability to form both intra- and intermolecular
hydrogen bonding and increases the hydrophobic interaction
with other membrane components within the membrane plane,
and more importantly this property enables sphingomyelins to
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FIGURE 2 | Comparison of experimental and model predicted membrane features. (A) Lipid groups composition in cell membrane in different conditions (data
on Table S1). (B) Lipid groups composition in lipid rafts in different conditions (data on Table S2). (C) Model predicted lipid rafts composition (data on Table S3). (D)
Comparison between model based values of mobility (dashed line) and experimental values of microviscosity (continuous line) in the membrane domain (data on Table
S4). (E) Model predicted number (continuous line) and size (dashed line, as measured by the mean radius) of lipid rafts (data on Table S5). (F) Model prediction rafts
proportion in membrane. W3; W6; W9; W14: Wild-type mice at 3, 6, 9, and 14 months of age. A3; A6; A9; A14: APP/PS1 transgenic mice of 3, 6, 9, and 14 months
of age, respectively. Vertical red lines separate Wild-type and AD induced conditions (data on Table S6). All the experimental data in this figure were taken from Fabelo
et al. (2012).
participate in transbilayer hydrocarbon interdigitation (Slotte,
1999; Sonnino and Prinetti, 2010). In order to characterize and
represent this feature we defined the interdigitating parameter
and introduced a parameter that decrease its switching between
the membrane leaflets, as most sphingomyelin is located in the
external leaflets of the membrane. We found that the model
predicts that the sphingolipids probability of switching is ∼10%
lower than for the other lipid groups.
Lipid Shape Parameters and Van der Waals
Forces
Table 1 shows the estimated parameters of the set of cylinders
that better encase the membrane lipids considered in this study,
these including length, width, mean intermolecular distance, and
the Hamaker constant.
Other relevant parameters for the model are the interaction
forces between the same lipid molecules. These interaction values
were calculated as indicated by Equation 1 and are shown in
Table 2. It can be seen that the strongest interactions occur for
saturated fatty acids and sphingolipids, and the weakest for n-6
LCPUFA.
Also relevant are the interactions amongst different lipid
groups (Table 3). In this case, the strongest interactions are
observed for sphingolipids and saturated fatty acids. On the
other hand, the n-6 LCPUFA group displays the lowest
interaction values. Overall, these estimates indicate that lipid
raft domains exhibit stronger interaction forces because their
particular enrichment in sphingolipids, saturates, and sterols,
which is in agreement the restricted lateral mobility and higher
compressibility compared to non-raft regions, which, in turn, are
depleted of sphingolipids but enriched in polyunsaturated (n-
3 and n-6 LCPUFA) whose pair interacting forces are weakest.
Therefore, based on the biochemical composition of the model
can predict phase segregation and domain formation in nerve cell
membranes.
Microviscosity Quantification in Rafts and
Non-rafts Fractions Membranes
The experimentally determined values of apparent
microviscosity (ηapp) in lipid rafts and non-raft fractions
(see Section Materials and Methods) are shown in Table 4.
Microviscosity is a membrane environmental property that
measures the difficulty for a probe to move in the membrane.
We have used the DPH probe as a hydrophobic probe that
buries within the membrane core. As it can be seen in Table 4,
lipid rafts display higher values of ηapp compared to non-
raft fractions in all groups of animals irrespective of their
genotype. However, these values tend to be higher in lipid
rafts from APP/PS1 transgenic AD mice. Moreover, paralleling
these observations it can be observed that in both genotypes,
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FIGURE 3 | Simulation of cell membrane lipid composition under different conditions. W, Wild-type mice; A, APP/PS1 transgenic mice; ages, 3, 6, 9, and 14
months. Color scale indicates mobility. Panels (A–H) corresponds to conditions: wild-type 3, 6, 9, and 14 months, APP/PS1 3, 6, 9, and 14 months, respectively.
TABLE 1 | Data based estimation (Diaz et al., 2012) of the cylinders
representing the modeled lipid membrane.
Width (radius Å) Length (Å)
Sterols 5.94 19.99
DHA 6.74 19.01
n-6 LCPUFA 5.84 17.70
Monoenoic fatty acids 5.30 22.59
Saturated fatty acids 6.14 22.44
Sphingolipids 6.18 22.44
Intermolecular distante (Å) 1.5
Hamaker constant 9.70 × 10−19
Sterols include cholesterol and sterol esters. The Hamaker constant comes from the
non-retarded and additive London-Van der Waals (LVW) attraction (Hamaker, 1937;
Israelachvili, 2011).
increased age leads to more viscous domains. It can also be
observed that experimental extraction of cholesterol using
methyl-β-cyclodextrine (MβCD) brought about a considerable
reduction of ηapp in all fractions, which was more dramatic
and severe in lipid rafts, therefore reinforcing the notion that
cholesterol (and sterols) and critical components particularly
enriched in lipid rafts and largely responsible for their higher
viscosity.
Based in our mathematical representation we can calculate a
closely microviscosity related magnitude, the mobility. Mobility
is also a medium property, which measures the facility of
movements of molecule in the membrane. It is thus the
TABLE 2 | Mean force of interaction between lipid groups.
Lipid groups Mean forces (N)
Sterols 1.05 × 10−18
DHA 1.04 × 10−18
n-6 LCPUFA 9.48 × 10−19
Monoenoic fatty acids 1.08 × 10−18
Saturated fatty acids 1.12 × 10−18
Sphingolipids 1.12 × 10−18
Forces are measured in Newtons (N). Sterols include cholesterol and sterol esters.
inverse of the microviscosity. As can be seen in Figure 2D
the model predicted mobility values correlates with the
experimental microviscosity data. This constitutes a posteriori
model verification.
Proportion, Number, and Size of Lipid Raft
Based in our model we could determine the ratio of lipid
rafts/total membrane and the number and mean size of lipid
rafts. Results are show in Figures 2E,D. Figure 2E it can be seen
that in Wild-type mice the number of lipid rafts increase until
the age of 6 months and then decrease. The observed pattern
in APP/PS1 mice is different since the decrease of the number
of domains after 6 months is initially sharper than in Wild-type
animals and then remains stable. Regarding the mean size of lipid
rafts, we find striking differences as well. Thus, inWild-typemice,
the mean radius remained constant until the age of 6 months,
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TABLE 3 | Pairs mean force interactions amongst the different lipid groups measured in Newtons (N).
Forces
Lipid Sterols DHA n-6 LCPUFA Monoenoic fatty acids Saturates fatty acids Sphingolipids
Sterols 1.07× 10−18 1.05× 10−18 9.45× 10−19 1.04× 10−18 1.08× 10−18 1.08× 10−18
DHA 1.09× 10−18 9.74× 10−19 1.02× 10−18 1.06× 10−18 1.06× 10−18
n-6 LCPUFA 9.41× 10−19 9.18× 10−19 9.53× 10−19 9.55× 10−19
Monoenoic fatty acids 1.14× 10−18 1.18× 10−18 1.18× 10−18
Saturated fatty acids 1.22× 10−18 1.23× 10−18
Sphingolipids 1.23× 10−18
Sterols include cholesterol and sterol esters.
TABLE 4 | Microviscosity values (ηapp) of lipid rafts (LR) and non-rafts (NR) domains proved with DPH.
W6 A6 W14 A14
NR LR NR LR NR LR NR LR
Microviscosity app (ηapp) 0.847 1.409 0.711 1.937 0.732 1.448 0.691 1.822
Microviscosity appMβCD(ηapp) 0.645 0.691 0.602 0.644 0.698 0.748 0.531 0.809
Percent reduction −23.813 −14.825 −15.329 −42.168 −4.629 −10.206 −23.244 −22.859
Microviscosity ctrl (38◦C) 8.525 14.193 7.157 19.503 7.374 14.578 6.962 18.345
Microviscosity MβCD (38◦C) 3.416 7.672 3.188 9.722 3.700 6.887 2.811 12.198
APP/WT (6 months old) 83.950 137.412
APP/WT (14 months old) 94.412 125.834
MβCD, methyl-β-cyclodextrine.
but then decreased and lastly the size increased at 14 months. In
contrast, in APP/PS1 mice, lipid rafts sizes were smaller than in
the Wild-type strain in the youngest animals and then increased
significantly after the age of 6 months. Moreover, the evolution
of the proportion of lipid rafts on the membrane (Figure 2F)
followed the same pattern than the domain size in both Wild-
type and APP/PS1 mice. Since the proportion of raft depends on
both, the raft size and number, the model thus indicates that the
relevant factor here is the size. Interestingly, for both parameters,
the time-course of age-related changes in the number and size of
lipid rafts, appear to be accelerated in APP/PS1 mice compared
to Wild-type animals.
The Possibility that AD-like Pathology can
be Modified
Provided with a reliable model representation we decided to
explore what sort of conditions could delay the onset of AD-
related lipid alterations, as assessed by the size of lipid rafts
being the variable which best correlates with raft proportion (see
Figures 2E,F). We explored this in the 9-month APP/PS1 mice.
We chose this condition because animal group is older enough
to display the pathological changes measured in brain cortex raft
membranes (Aso et al., 2012; Fabelo et al., 2012) but at the same
time younger enough to allow a reversion of membrane lipids
alterations.
Figure 4 shows the results obtained after a 50% change
(increase or decrease) in each lipid group and compared
with the 3 months old Wild-type mice. It can be seen
FIGURE 4 | Changing lipid composition. Lipid raft size after increasing
each lipid proportion by 50% in the 9 months APP/PS1 transgenic mice (third
row) or decreasing it (fourth row). First row displays the data from 3 months old
Wild-type mice and second row the data from 9 months old APP/PS1
transgenic mice (data on Table S7). All the experimental data in this figure were
taken from Fabelo et al. (2012).
that there are three lipid groups (sterols, DHA, and n-6
LCPUFA) showing a significant decrease of lipid raft size
after an increase of their proportions by comparing first row
(3 months Wild-type) and third row (9 months APP/PS1).
The other three lipid groups (monoenoic, saturates, and
sphingolipids) drive an improvement in raft size when they
are reduced (first and fourth rows for WT and APP/PS1 mice,
respectively).
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DISCUSSION
In this work we present, the first attempt to quantify the evolution
of lipid rafts in Alzheimer’s disease by means an agent based
mathematical model supported by in vivo lipid data composition
of nerve cell membranes and their integrated domains, namely
lipid rafts and non-raft domains in Wild-type and APP/PS1
transgenic mice at 3, 6, 9, and 14 months. As mentioned
before, the original, in vivo data used here, derives from our
previous work on the detailed analyses of the lipid composition
of cortical lipid rafts and whole membrane fractions in these
same genotypes and determined at the same ages considered
here (Diaz et al., 2012; Fabelo et al., 2012). Moreover, some
biophysical and thermodynamic consequences of lipid changes
associated with aging have been experimentally determined,
particularly in cortical lipid rafts from APP/PS1 animals (Diaz
et al., 2012). However, at present there have nomodeling attempts
to modify lipid compositions and lipid domain formation in vivo
in order to modify nerve cell membranes in the central nervous
system in animal models of AD. The objective of this work
was to build up a mathematical model aiming at delving into
how molecular alterations in the lipid composition of these
domains (raft and non-raft) influence not only their biophysical
properties but also their formation and stability. To strength
the significance of the predictions, the present agent based
mathematical model was calibrated with the real experimental
data.
As it has been shown in Figure 2, themodel was able to predict
the lipid composition of lipid rafts. Lipid rafts microdomains,
defined as nanoscopic membrane regions involved in a
number signaling processes, with specific lipid composition
and differential physicochemical properties compared to
their surrounding (non-raft) membrane domains (Brown
and London, 2000; Pike, 2006), show mobility values around
30% lower than in the whole membrane or non-raft domains.
The model also showed that the presence of sphingolipids
provides interdigitation between the two membrane leaflets.
The occurrence of this mechanism is responsible of about 10%
mobility reduction of sphingolipids, which, in turn, is reinforced
by its interaction with saturates and sterols (Barenholz and
Thompson, 1980). In addition, since interdigitation influences
lateral mobility and compressibility (Maulik et al., 1986), this
observation could also explain its stability and higher lipid
density within raft domains.
The evaluation of interaction forces between each lipid group
and amongst distinct lipid groups (Table 2) show that highly
unsaturated lipids (DHA and n-6 LCPUFA groups) exhibit
weak interactions between them as well as with sterols, while
monoenes, display intermediate interaction force values. At
the other end, saturated fatty acids and sphingolipids are the
lipid groups showing the strongest interactions. This graduation
correlates well with the molecular structures, from the weakest
interacting (corresponding to the more twisted molecules, the
polyunsaturated fatty acids) to the strongest (the linear; saturated
fatty acid).
In addition to this, we have observed that cholesterol strongly
interacts with saturated lipids and sphingolipids, which is
in agreement with the umbrella effect (Róg and Vattulainen,
2014) (see Table 3). Another model verification comes from the
observation that DHAmolecules interact more strongly amongst
them than with other lipids; an observation in accordance with
the role of DHA as dissociating structures in cell domains
(Jicha and Markesbery, 2010) which largely contribute to phase
separation within the membrane hemilayer (Shaikh et al., 2009;
Sonnino and Prinetti, 2010; Georgieva et al., 2015), and likely
give rise to the generation of DHA-rich domains bordering (and
stabilizing) lipid rafts within nerve cell membranes (Wassall and
Stillwell, 2008).
Microviscosity was experimentally determined in lipid rafts
and also in non-raft regions surrounding the membrane rafts in
Wild-type and AD transgenic mice at different ages (Table 4).
The obtained values were found to correlate with themodel based
mobility values; being these results, at least in part, a sort of
experimental model verification.
Furthermore, these observations give new insights regarding
the evolution of AD, at least in this transgenic model of familial
AD. Thus, we have observed that mobility outside lipid raft
domains in AD mice of 6 and 14 months is greater than
in Wild-type mice of the same age (Figure 2D). This entails
that in the AD conditions lipids and proteins in non-raft
regions might move more freely than in lipid rafts, which, in
turn, appear to be more viscous, with lipid and protein lateral
movements being more restricted in the APP/PS1 mice. In
fact, experimental microviscosity values agree with the model
predictions.
Based in these observations we propose a mechanism to
explain whereby there is an increased production of β-amyloid
in AD brain cortex. Since there is a greater molecular mobility
outside lipid rafts in these conditions, the entry rate of APP
into lipid rafts would be augmented and therefore the rate of
amyloidogenic reactions catalyzed within the domain the by β-
and γ-secretases would be expected to increase, to the detriment
of APP processing in non-raft domains by the α-secretase. This
trend increase with aging in WT and APP/PS1 brains, but in
AD mice it is of higher magnitude. Since WT mice do not
exhibit senile plaques and very low levels of amyloid peptides
throughout their lifespan (Aso et al., 2012), there should exist
a lipid alteration threshold (probably determined by the level
of DHA depletion) above which lipid mobility around lipid
rafts would favor the incorporation of APP into lipid rafts. We
thus suggest that the increased molecular mobility in non-raft
domains is a condition that exacerbates during aging and plays
a central role in the observed increase of amyloid β-production
in AD patients. In agreement, we have recently demonstrated
in human brains that the accumulation of APP and β-secretase
in lipid raft is a determinant factor in amyloidogenic APP
processing, and that this is an early event in the development
of the disease (Fabelo et al., 2014). Also in line with our
hypothesis, Das et al. (2013) have demonstrated that convergence
of APP and BACE-1 within lipid rafts via an endocytic-dependent
pathway triggers the increase of β-secretase cleavage activity,
which eventually favors the generation of senile plaques. In
addition, the aberrant organization of lipid rafts predicted here in
AD brains might be related to the disarrangement of degradative
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autophagic-lysosomal pathway of β-amyloid peptides observed
in AD (Zhou et al., 2014), which, in turn, would facilitate its
accumulation.
We have been able also to predict the time-course of age-
associated changes in the number, mean size and proportion
of lipid raft domains both in Wild-type and APP/PS1 mice
(shown in Figures 2E,F). In both genotypes, the number of rafts
decreases with aging, but in APP/PS1 mice this occurs earlier and
more abruptly, which is in agreement with previous experimental
data. However, the good correlation between rafts proportion
and raft sizes indicates that the determinant factor to explain
the surface increase of rafts is the increase in radius, not its
number. Regarding lipid raft sizes and proportion there is an
opposite trend with respect to the number of rafts, since the
mean radius and proportion increase with age. But, again, the
change is sharper in APP/PS1 mice. These results point to the
fact that, since we should expect to find a bigger area in the cell
membrane as lipid rafts in older individuals, there would exist
an increased amount of lipid rafts-associated signaling molecules
interacting and likely higher molecular activity in these cases,
as suggested by Marin et al. (2013). This situation leads to an
unbalanced physiological condition that can be cause and, at
the same time, consequence of the aging process. We suggest
that homeostatic mechanisms should be operating to control the
lipid rafts proportion (in terms of size and number). Perhaps, the
reduction of lipid rafts proportion observed in Wild-type mice
between 6 and 9 months might be a cellular response to these
mechanisms, which appear disrupted in APP/PS1 mice. In the
AD mice model the situation becomes somewhat extreme: the
increase in rafts proportion occurs earlier and are exacerbated
compared to WT. This prediction supports the hypothesis of
accelerated “lipid raft aging” that we have previously postulated
for this same transgenic mice model of AD (Fabelo et al., 2012).
Furthermore, raft proportion in 3 months-old AD mice was
predicted to be smaller than in Wild-type animals at the same
age. Since in these mice, β-amyloid is produced since the first
months of age (Aso et al., 2012), it is suggested that this is
an early effect on homeostatic mechanisms controlling the size
and proportion of these microdomains. The increase in lipid
domains observed later may well reflect the disarrangement of
this controlling mechanism. In the same vein as the production
of β-amyloid occurs inside lipid rafts, any increase of the
raft area during aging would increase the accumulation of all
components of amyloidogenic machinery, eventually leading
to increased production of β-amyloid. We propose that the
increased proportion of lipid rafts is one of the consequences of
aging, and that this trend is accelerated in AD patients, which can
positively feedback the production of β-amyloid. Interestingly,
the prediction that lipid rafts sizes increase prematurely might be
extrapolated to human AD patients at early stages of the disease,
where not only alterations in the lipid matrix and biophysical
properties occur (Díaz et al., 2015), but also the accumulation
of APP and γ- and β-secretases as well as their association are
increased (Fabelo et al., 2014).
What sort of changes in the lipidmatrix could delay or prevent
these age-related events? As we stated in the last paragraph,
the parameter of domains which best correlates aging and AD
evolution is the domain size. This measure was used here as an
indicator of the restoring, by comparing for each lipid species
the original situation with the situation after modifying one lipid
group each time. Taking as reference of the healthy state the 3
month-old Wild-type mice, and the pathological condition to be
restored that of the 9 month-old AD mice, we explored different
scenarios and found out that the best strategies to partially restore
a healthy condition were either, increasing the amount of sterols
(mainly cholesterol), DHA, and n-6 LCPUFA or decreasing
monoenoic, saturates, and sphingolipids, separately. Figure 4
displays some of these results. It is interesting to note that the
healthy effects of the DHA intake on the evolution of AD has
been already stablished by a number of epidemiological studies
(Jicha and Markesbery, 2010), which constitutes an additional,
a posteriori, model validation. The other strategy was increasing
sterols in lipid rafts. However, the role of cholesterol in the
onset and progression of AD remains controversial (Ledesma
and Dotti, 2005; Martins et al., 2009; Gamba et al., 2012; Martín
et al., 2014) and most studies has not yet been proved to
have a positive effect on AD. In fact, most epidemiological
and experimental studies on cholesterol have shown a negative
effect on AD progression (Martins et al., 2009; Gamba et al.,
2012; Maulik et al., 2013). The controversy about the role of
cholesterol in AD remains unsolved, however, we have recently
postulated a reconciling hypothesis according to which it is
the balance between cholesterol and DHA in lipid raft (which
affect membrane viscosity of opposite ways), rather than their
individual contents, what mostly affect the physicochemical
and thermodynamic properties of these domains, eventually
impacting the rate of amyloidogenic processing of APP (Díaz
et al., 2015).
CONCLUSIONS
The mathematical, agent based model, presented here is able
to provide a quantitative assessment of the effect of lipid rafts
alterations on some aspects of the progression of AD in relation
to the progress of aging. The model was based on previous
experimental data of lipid composition and biophysical analyses
in whole membrane and lipid domains obtained from Wild-type
mice and in a familial model of AD at different ages.
The outcomes indicate that changes in the proportion of
lipid rafts (and lipid rafts radius) occur naturally along aging
and that this process is accelerated in AD mice, which can
positively feedback the production of β-amyloid. We suggest
that the mechanisms controlling the domain size are critical
in AD evolution. Also, we found increased lipid mobility
in non-raft domains associated with aging; this phenomena
being even greater in AD. We speculate that both factors,
i.e., larger raft domains and higher non-raft lipid mobility
would favor amyloidogenic machinery to increase β-amyloid
production.
Based on our findings we propose to claim about the
importance of sterols and LCPUFA present in the cell membrane
domains on the progression of AD and on the potential benefits
of these lipid species in delaying the onset of AD.
Frontiers in Physiology | www.frontiersin.org 10 March 2016 | Volume 7 | Article 90
Santos et al. Mathematical Modeling of Membrane Microdomains
AUTHOR CONTRIBUTIONS
GS and NT designed the agent-based model. MD performed
experminental work. GS, NT, and MD prepared, discussed, and
wrote the manuscript.
ACKNOWLEDGMENTS
This work was funded by research grants from BIO2014-54411-
C2-2-R and SAF2014-52582-R from Ministerio de Economía
y Competitividad (MINECO, Spain). GSR acknowledges the
support of Obra Social La Caixa-Fundación CajaCanarias that
granted him a Posgraduate Fellowship at the Universidad de La
Laguna.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphys.
2016.00090
REFERENCES
Aso, E., Lomoio, S., López-González, I., Joda, L., Carmona, M., Fernández-Yagüe,
N., et al. (2012). Amyloid generation and dysfunctional immunoproteasome
activation with disease progression in animal model of familial Alzheimer’s
disease. Brain Pathol. 22, 636–653. doi: 10.1111/j.1750-3639.2011.
00560.x
Baoukina, S., Mendez-Villuendas, E., and Tieleman, D. P. (2012). Molecular view
of phase coexistence in lipid monolayers. J. Am. Chem. Soc. 134, 17543–17553.
doi: 10.1021/ja304792p
Barenholz, Y., and Thompson, T. E. (1980). Sphingomyelins in bilayers and
biological membranes. Biochim. Biophys. Acta 604, 129–158.
Barnoud, J., Rossi, G., Marrink, S. J., and Monticelli, L. (2014). Hydrophobic
compounds reshape membrane domains. PLoS Comput. Biol. 10:e1003873. doi:
10.1371/journal.pcbi.1003873
Bennett, W. F. D., and Tieleman, D. P. (2013). Computer simulations of
lipid membrane domains. Biochim. Biophys. Acta 1828, 1765–1776. doi:
10.1016/j.bbamem.2013.03.004
Blennow, K., de Leon, M. J., and Zetterberg, H. (2006). Alzheimer’s disease. Lancet
368, 387–403. doi: 10.1016/S0140-6736(06)69113-7
Brown, D. A., and London, E. (2000). Structure and function of sphingolipid-
and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 17221–17224. doi:
10.1074/jbc.R000005200
Burrage, K., Hancock, J., Leier, A., and Nicolau, D. V. (2007). Modelling and
simulation techniques for membrane biology. Brief. Bioinformatics 8, 234–244.
doi: 10.1093/bib/bbm033
Claeysen, S., Cochet, M., Donneger, R., Dumuis, A., Bockaert, J., and Giannoni,
P. (2012). Alzheimer culprits: cellular crossroads and interplay. Cell. Signal. 24,
1831–1840. doi: 10.1016/j.cellsig.2012.05.008
Das, U., Scott, D. A., Ganguly, A., Koo, E. H., Tang, Y., and Roy,
S. (2013). Activity-induced convergence of APP and BACE-1 in acidic
microdomains via an endocytosis-dependent pathway. Neuron 79, 447–460.
doi: 10.1016/j.neuron.2013.05.035
Davis, R. S., Sunil Kumar, P. B., Sperotto, M. M., and Laradji, M. (2013).
Predictions of phase separation in three-component lipid membranes by the
MARTINI force field. J. Phys. Chem. B 117, 4072–4080. doi: 10.1021/jp40
00686
de Joannis, J., Coppock, P. S., Yin, F., Mori, M., Zamorano, A., and Kindt, J. T.
(2011). Atomistic simulation of cholesterol effects on miscibility of saturated
and unsaturated phospholipids: implications for liquid-ordered/liquid-
disordered phase coexistence. J. Am. Chem. Soc. 133, 3625–3634. doi:
10.1021/ja110425s
de Laat, S. W., van der Saag, P. T., and Shinitzky, M. (1977). Microviscosity
modulation during the cell cycle of neuroblastoma cells. Proc. Natl. Acad. Sci.
U.S.A. 74, 4458–4461. doi: 10.1073/pnas.74.10.4458
Díaz, M., Fabelo, N., Martín, V., Ferrer, I., Gómez, T., and Marín, R. (2015).
Biophysical alterations in lipid rafts from human cerebral cortex associate
with increased BACE1/AβPP interaction in early stages of Alzheimer’s disease.
J. Alzheimers Dis 43, 1185–1198. doi: 10.3233/JAD-141146
Diaz, M. L., Fabelo, N., and Marín, R. (2012). Genotype-induced changes
in biophysical properties of frontal cortex lipid raft from APP/PS1
transgenic mice. Front. Physiol. 3:454. doi: 10.3389/fphys.2012.
00454
Fabelo, N., Martín, V., Marín, R., Moreno, D., Ferrer, I., and Díaz, M. (2014).
Altered lipid composition in cortical lipid rafts occurs at early stages
of sporadic Alzheimer’s disease and facilitates APP/BACE1 interactions.
Neurobiol. Aging 35, 1801–1812. doi: 10.1016/j.neurobiolaging.2014.
02.005
Fabelo, N., Martín, V., Santpere, G., Aso, E., Ferrer, I., and Díaz, M. (2012).
Evidence for premature ‘Lipid raft aging’ in APP/PS1 double transgenic mice, a
familial model of Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 71, 858–881.
doi: 10.1097/NEN.0b013e31826be03c
Farooqui, A. A., Horrocks, L. A., and Farooqui, T. (2000). Glycerophospholipids
in brain: their metabolism, incorporation into membranes, functions, and
involvement in neurological disorders. Chem. Phys. Lipids 106, 1–29. doi:
10.1016/S0009-3084(00)00128-6
Finegold, L. (1993). Cholesterol in Membrane Models. Boca Ratón, FL: CRC Press.
Fischer, T., Risselada, H. J., and Vink, R. L. C. (2012). Membrane lateral structure:
the influence of immobilized particles on domain size. Phys. Chem. Chem. Phys.
14, 14500–14508. doi: 10.1039/c2cp41417a
Gamba, P., Testa, G., Sottero, B., Gargiulo, S., Poli, G., and Leonarduzzi, G.
(2012). The link between altered cholesterol metabolism and Alzheimer’s
disease. Ann. N.Y. Acad. Sci. 1259, 54–64. doi: 10.1111/j.1749-6632.2012.
06513.x
Georgieva, R., Chachaty, C., Hazarosova, R., Tessier, C., Nuss, P.,
Momchilova, A., et al. (2015). Docosahexaenoic acid promotes micron
scale liquid-ordered domains. A comparison study of docosahexaenoic
versus oleic acid containing phosphatidylcholine in raft-like mixtures.
Biochim. Biophys. Acta 1848, 1424–1435. doi: 10.1016/j.bbamem.2015.
02.027
Hakobyan, D., andHeuer, A. (2013). Phase separation in a lipid/cholesterol system:
comparison of coarse-grained and united-atom simulations. J. Phys. Chem. B
117, 3841–3851. doi: 10.1021/jp312245y
Hamaker, H. C. (1937). The London-Van der Waals attraction between
spherical particles. Physica 10, 1058–1072. doi: 10.1016/s0031-8914(37)
80203-7
Han, J.-Y., and Han, S.-H. (2014). Primary prevention of Alzheimer’s
disease: is it an attainable goal? J. Korean Med. Sci. 29, 886–892. doi:
10.3346/jkms.2014.29.7.886
Herrera, F. E., and Pantano, S. (2012). Structure and dynamics of nano-sized
raft-like domains on the plasma membrane. J. Chem. Phys. 136:015103. doi:
10.1063/1.3672704
Hicks, D. A., Nalivaeva, N. N., and Turner, A. J. (2012). Lipid rafts and Alzheimer’s
disease: protein-lipid interactions and perturbation of signaling. Front. Physiol.
3:189. doi: 10.3389/fphys.2012.00189
Holtzman, D. M., John, C. M., and Goate, A. (2011). Alzheimer’s disease:
the challenge of the second century. Sci. Trans. Med. 3, 77sr1. doi:
10.1126/scitranslmed.3002369
Israelachvili, J. N. (2011). Intermolecular and Surface Forces, 3rd Edn. London:
Academic Press.
Jicha, G. A., and Markesbery, W. R. (2010). Omega-3 fatty acids: potential role in
the management of early Alzheimer’s disease. Clin. Interv. Aging 5, 45–61. doi:
10.2147/CIA.S5231
Klymchenko, A. S., and Kreder, R. (2014). Fluorescent probes for lipid rafts:
from model membranes to living cells. Chem. Biol. 21, 97–113. doi:
10.1016/j.chembiol.2013.11.009
Frontiers in Physiology | www.frontiersin.org 11 March 2016 | Volume 7 | Article 90
Santos et al. Mathematical Modeling of Membrane Microdomains
Kucerka, N., Marquardt, D., Harroun, T. A., Nieh, M.-P., Wassall, S. R., de
Jong, D. H., et al. (2010). Cholesterol in bilayers with PUFA chains: doping
with DMPC or POPC results in sterol reorientation and membrane-domain
formation. Biochemistry 49, 7485–7493. doi: 10.1021/bi100891z
Kumar, V. V. (1991). Complementary molecular shapes and additivity of the
packing parameter of lipids. Proc. Natl. Acad. Sci. U.S.A. 88, 444–448. doi:
10.1073/pnas.88.2.444
Lakowicz, J. R. (1999). Principles of Fluorescence Spectroscopy. New York, NY:
Kluwer Academic/Plenum Publisher.
Ledesma, M. D., and Dotti, C. G. (2005). The conflicting role of brain cholesterol in
Alzheimer’s disease: lessons from the brain plasminogen system. Biochem. Soc.
Symp. 72, 129–138. doi: 10.1042/bss0720129
Loy, C. T., Schofield, P. R., Turner, A. M., and Kwok, J. B. J. (2014).
Genetics of dementia. Lancet 383, 828–840. doi: 10.1016/S0140-6736(13)
60630-3
Marin, R., Rojo, J. A., Fabelo, N., Fernandez, C. E., and Diaz, M. (2013).
Lipid raft disarrangement as a result of neuropathological progresses:
a novel strategy for early diagnosis? Neuroscience 245, 26–39. doi:
10.1016/j.neuroscience.2013.04.025
Marrink, S. J., and Tieleman, D. P. (2013). Perspective on theMartini model.Chem.
Soc. Rev. 42, 6801–6822. doi: 10.1039/c3cs60093a
Marrink, S. J., de Vries, A. H., Harroun, T. A., Katsaras, J., and Wassall, S. R.
(2008). Cholesterol shows preference for the interior of polyunsaturated
lipid membranes. J. Am. Chem. Soc. 130, 10–11. doi: 10.1021/ja07
6641c
Martín, M. G., Pfrieger, F., and Dotti, C. G. (2014). Cholesterol in brain disease:
sometimes determinant and frequently implicated. EMBO Rep. 15, 1036–1052.
doi: 10.15252/embr.201439225
Martín, V., Fabelo, N., Santpere, G., Puig, B., Marín, R., Ferrer, I., et al. (2010).
Lipid alterations in lipid rafts from Alzheimer’s disease human brain cortex.
J. Alzheimers Dis. 19, 489–502. doi: 10.3233/JAD-2010-1242
Martins, I. J., Berger, T., Sharman, M. J., Verdile, G., Fuller, S. J., and Martins,
R. N. (2009). Cholesterol metabolism and transport in the pathogenesis
of Alzheimer’s disease. J. Neurochem. 111, 1275–1308. doi: 10.1111/j.1471-
4159.2009.06408.x
Maulik, M., Westaway, D., Jhamandas, J. H., and Kar, S. (2013). Role of cholesterol
in APP metabolism and its significance in Alzheimer’s disease pathogenesis.
Mol. Neurobiol. 47, 37–63. doi: 10.1007/s12035-012-8337-y
Maulik, P. R., and Shipley, G. G. (1996). Interactions of N-stearoyl
sphingomyelin with cholesterol and dipalmitoylphosphatidylcholine in
bilayer membranes. Biophys. J. 70, 2256–2265. doi: 10.1016/S0006-3495(96)
79791-6
Maulik, P. R., Atkinson, D., and Shipley, G. G. (1986). X-ray scattering
of vesicles of N-acyl sphingomyelins. Determination of bilayer
thickness. Biophys. J. 50, 1071–1077. doi: 10.1016/S0006-3495(86)
83551-2
Muddana, H. S., Chiang, H. H., and Butler, P. J. (2012). Tuning membrane
phase separation using nonlipid amphiphiles. Biophys. J. 102, 489–497. doi:
10.1016/j.bpj.2011.12.033
Müller, W. E., Kirsch, C., and Eckert, G. P. (2001). Membrane-disordering
effects of beta-amyloid peptides. Biochem. Soc. Trans. 29(Pt 4), 617–623. doi:
10.1042/bst0290617
Nicolau, D. V. Jr., Burrage, K., Parton, R. G., and Hancock, J. F. (2006). Identifying
optimal lipid raft characteristics required to promote nanoscale protein-protein
interactions on the plasma membrane. Mol. Cell. Biol. 26, 313–323. doi:
10.1128/MCB.26.1.313-323.2006
Nicolau, D. V. Jr., Hancock, J. F., and Burrage, K. (2007). Sources of anomalous
diffusion on cell membranes: a Monte Carlo study. Biophys. J. 92, 1975–1987.
doi: 10.1529/biophysj.105.076869
Nicolson, G. L. (2014). The Fluid-mosaic model of membrane structure: still
relevant to understanding the structure, function and dynamics of biological
membranes after more than 40 years. Biochim. Biophys. Acta 1838, 1451–1466.
doi: 10.1016/j.bbamem.2013.10.019
Perlmutter, J. D., and Sachs, J. N. (2009). Inhibiting lateral domain
formation in lipid bilayers: simulations of alternative steroid headgroup
chemistries. J. Am. Chem. Soc. 131, 16362–16363. doi: 10.1021/ja90
79258
Perlmutter, J. D., and Sachs, J. N. (2011). Interleaflet interaction and asymmetry in
phase separated lipid bilayers: molecular dynamics simulations. J. Am. Chem.
Soc. 133, 6563–6577. doi: 10.1021/ja106626r
Pike, L. J. (2006). Rafts defined: a report on the Keystone symposium on lipid rafts
and cell function. J. Lipid Res. 47, 1597–1598. doi: 10.1194/jlr.E600002-JLR200
Postina, R. (2012). Activation of α-secretase cleavage. J. Neurochem. 120(Suppl. 1),
46–54. doi: 10.1111/j.1471-4159.2011.07459.x
Richardson, G., Cummings, L. J., Harris, H. J., and O’Shea, P. (2007). Toward
a mathematical model of the assembly and disassembly of membrane
microdomains: comparison with experimental models. Biophys. J. 92,
4145–4156. doi: 10.1529/biophysj.106.090233
Risselada, H. J., and Marrink, S. J. (2008). The molecular face of lipid rafts
in model membranes. Proc. Natl. Acad. Sci. U.S.A. 105, 17367–17372. doi:
10.1073/pnas.0807527105
Risselada, H. J., Marrink, S. J., and Müller, M. (2011). Curvature-dependent
elastic properties of liquid-ordered domains result in inverted domain
sorting on uniaxially compressed vesicles. Phys. Rev. Lett. 106:148102. doi:
10.1103/physrevlett.106.148102
Róg, T., and Vattulainen, I. (2014). Cholesterol, sphingolipids, and
glycolipids: what do we know about their role in raft-like membranes?
Chem. Phys. Lipids 184, 82–104. doi: 10.1016/j.chemphyslip.2014.
10.004
Rosetti, C., and Pastorino, C. (2011). Polyunsaturated and saturated phospholipids
in mixed bilayers: a study from the molecular scale to the lateral
lipid organization. J. Phys. Chem. B 115, 1002–1013. doi: 10.1021/jp10
82888
Rosetti, C., and Pastorino, C. (2012). Comparison of ternary bilayer mixtures with
asymmetric or symmetric unsaturated phosphatidylcholine lipids by coarse
grained molecular dynamics simulations. J. Phys. Chem. B 116, 3525–3537. doi:
10.1021/jp212406u
Rushworth, J. V., and Hooper, N. M. (2010). Lipid rafts: linking
alzheimer’s amyloid-β production, aggregation, and toxicity at neuronal
membranes. Int. J. Alzheimers Dis. 2011:603052. doi: 10.4061/2011/
603052
Schäfer, L. V., andMarrink, S. J. (2010). Partitioning of lipids at domain boundaries
in model membranes. Biophys. J. 99, L91–L93. doi: 10.1016/j.bpj.2010.
08.072
Shaikh, S. R., Rockett, B. D., Salameh, M., and Carraway, K. (2009).
Docosahexaenoic acid modifies the clustering and size of lipid rafts and the
lateral organization and surface expression of MHC class I of EL4 cells. J. Nutr.
139, 1632–1639. doi: 10.3945/jn.109.108720
Simons, K., and Ehehalt, R. (2002). Cholesterol, lipid rafts, and disease. J. Clin.
Invest. 110, 597–603. doi: 10.1172/JCI0216390
Slotte, J. P. (1999). Sphingomyelin-cholesterol interactions in biological and
model membranes. Chem. Phys. Lipids 102, 13–27. doi: 10.1016/S0009-
3084(99)00071-7
Sonnino, S., and Prinetti, A. (2010). Lipids and membrane lateral organization.
Front. Physiol. 1:153. doi: 10.3389/fphys.2010.00153
Sonnino, S., and Prinetti, A. (2013). Membrane domains and the ‘lipid raft’
concept. Curr. Med. Chem. 20, 4–21. doi: 10.2174/0929867311320010003
Soula, H. A., Coulon, A., and Beslon, G. (2012). Membrane microdomains
emergence through non-homogeneous diffusion. BMC Biophys. 5:6. doi:
10.1186/2046-1682-5-6
Tanzi, R. E. (2012). The genetics of Alzheimer disease. Cold Spring Harb. Perspect.
Med. 2:a006296. doi: 10.1101/cshperspect.a006296
Vetrivel, K. S., and Thinakaran, G. (2010). Membrane rafts in Alzheimer’s
disease beta-amyloid production. Biochim. Biophys. Acta 1801, 860–867. doi:
10.1016/j.bbalip.2010.03.007
Wassall, S. R., and Stillwell, W. (2008). Docosahexaenoic acid domains: the
ultimate non-raft membrane domain. Chem. Phys. Lipids 153, 57–63. doi:
10.1016/j.chemphyslip.2008.02.010
Wood, W. G., Schroeder, F., Igbavboa, U., Avdulov, N. A., and Chochina,
S. V. (2002). Brain membrane cholesterol domains, aging and amyloid
beta-peptides. Neurobiol. Aging 23, 685–694. doi: 10.1016/S0197-4580(02)
00018-0
Wurthner, J. U., Mukhopadhyay, A. K., and Peimann, C. J. (2000).
A cellular automaton model of cellular signal transduction.
Frontiers in Physiology | www.frontiersin.org 12 March 2016 | Volume 7 | Article 90
Santos et al. Mathematical Modeling of Membrane Microdomains
Comput. Biol. Med. 30, 1–21. doi: 10.1016/S0010-4825(99)
00020-7
Zhang, J., Steinberg, S. L., Wilson, B. S., Oliver, J. M., and Williams, L. R.
(2008). Markov random field modeling of the spatial distribution of proteins
on cell membranes. Bull. Math. Biol. 70, 297–321. doi: 10.1007/s11538-007-
9259-0
Zhou, X., Yang, C., Liu, Y., Li, P., Yang, H., Dai, J., et al. (2014). Lipid
rafts participate in aberrant degradative autophagic-lysosomal pathway of
amyloid-beta peptide in Alzheimer’s disease. Neural Regen. Res. 9, 92–100. doi:
10.4103/1673-5374.125335
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Santos, Díaz and Torres. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 13 March 2016 | Volume 7 | Article 90
